UniQure Total Assets 2013-2022 | QURE
UniQure total assets from 2013 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
UniQure Annual Total Assets
(Millions of US $) |
| 2022 |
$705 |
| 2021 |
$809 |
| 2020 |
$340 |
| 2019 |
$449 |
| 2018 |
$274 |
| 2017 |
$210 |
| 2016 |
$190 |
| 2015 |
$263 |
| 2014 |
$127 |
| 2013 |
$52 |
| 2012 |
$7 |
UniQure Quarterly Total Assets
(Millions of US $) |
| 2022-09-30 |
$638 |
| 2022-06-30 |
$701 |
| 2022-03-31 |
$757 |
| 2021-12-31 |
$809 |
| 2021-09-30 |
$775 |
| 2021-06-30 |
$784 |
| 2021-03-31 |
$364 |
| 2020-12-31 |
$340 |
| 2020-09-30 |
$351 |
| 2020-06-30 |
$385 |
| 2020-03-31 |
$414 |
| 2019-12-31 |
$449 |
| 2019-09-30 |
$472 |
| 2019-06-30 |
$253 |
| 2019-03-31 |
$269 |
| 2018-12-31 |
$274 |
| 2018-09-30 |
$281 |
| 2018-06-30 |
$309 |
| 2018-03-31 |
$192 |
| 2017-12-31 |
$210 |
| 2017-09-30 |
$139 |
| 2017-06-30 |
$158 |
| 2017-03-31 |
$170 |
| 2016-12-31 |
$190 |
| 2016-09-30 |
$213 |
| 2016-06-30 |
$235 |
| 2016-03-31 |
$246 |
| 2015-12-31 |
$263 |
| 2015-09-30 |
$283 |
| 2015-06-30 |
$255 |
| 2015-03-31 |
$102 |
| 2014-12-31 |
$127 |
| 2014-09-30 |
$134 |
| 2014-06-30 |
$140 |
| 2014-03-31 |
$138 |
| 2013-12-31 |
$52 |
| 2013-09-30 |
$58 |
| 2012-12-31 |
$7 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.943B |
$0.106B |
|
UNIQURE B.V. is involved in developing gene therapy for patients of genetic or acquired diseases. It offers Glybera for the treatment of lipoprotein lipase deficiency, an orphan metabolic disease. The company's product pipeline includes which are in clinical trials are additional adeno-associated virus consist of AMT-060, AMT-021, AMT-110 and AAV2/glial. UNIQURE B.V. is headquartered in Amsterdam, the Netherlands.
|
